Skip to main content
logo
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
460.42
+0.14 (0.03%)
At close: Nov 6, 2026, 4:00 PM EST
459.47
-0.95 (-0.21%)
After-hours: Nov 6, 2026, 7:59 PM EST

Amgen Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
9,8839,5378,2189,3679,1378,7717,8738,7168,1518,0417,1187,8336,5486,6835,8466,5526,2376,2815,7316,271
Other Revenue
482517400499420408276370352347329363355303259287415313507575
Revenue
10,36510,0548,6189,8669,5579,1798,1499,0868,5038,3887,4478,1966,9036,9866,1056,8396,6526,5946,2386,846
Revenue Growth (YoY)
8.46%9.53%5.75%8.58%12.40%9.43%9.43%10.86%23.18%20.07%21.98%19.84%3.77%5.95%-2.13%-0.10%-0.80%1.04%5.71%3.20%
Cost of Revenue
2,7882,7512,4972,6762,7442,6722,6052,7122,6492,5762,5072,4561,8061,8131,7201,7471,5881,5101,5611,718
Gross Profit
7,5777,3036,1217,1906,8136,5075,5446,3745,8545,8124,9405,7405,0975,1734,3855,0925,0645,0844,6775,128
Selling, General & Admin
1,6801,7451,6021,9521,7201,6911,6871,8781,6251,7851,8081,7871,3531,2941,2581,5721,2871,3271,2281,425
Research & Development
2,1111,8681,7192,1421,9001,7441,4861,7241,4501,4471,3431,5341,0791,1131,0581,3241,1121,0399591,348
Other Operating Expenses
76116-11382-717730172711137-778791105-5811542--
Operating Expenses
3,8673,7293,2084,1763,5493,5123,2033,7743,1463,2433,1882,5433,2232,5122,3162,9542,4102,9082,1872,773
Operating Income
3,7103,5742,9133,0143,2642,9952,3412,6002,7082,5691,7523,1971,8742,6612,0692,1382,6542,1762,4902,355
Interest Expense
-653-673-657-1,061-685-694-723-1,257-776-808-824-2,046-759-752-543-542-368-328-295-335
Interest & Investment Income
---408---510---1,225---127----
Earnings From Equity Investments
------------134153-20292-104-80-160181
Currency Exchange Gain (Loss)
29-775-3917283-162121-3-3199-8651-22228-198-185-78-55
Other Non Operating Income (Expenses)
127145192143183-113-376226-1094234-26588336213-177210-4-242382
EBT Excluding Unusual Items
3,1863,0552,3712,5092,7232,3601,3251,9172,0431,8521,1312,3151,7702,2961,7372,0662,1941,5791,7152,528
Merger & Restructuring Charges
--60-247-300-338-339-363-400-661-660-693-1,143---143-----58
Gain (Loss) on Sale of Investments
1,500-227-130-7011,900-5701,700-8461,719-398-57123830-7051,853-488192-48-50-346
Gain (Loss) on Sale of Assets
---------------62----
Asset Writedown
-----400--800129---68-783--------
Other Unusual Items
--90636117111-18--13322514723-51086-107
Pretax Income
4,6862,7682,0841,5143,9211,5681,9737823,101794-688521,9471,6143,4421,7482,3921,5311,6752,131
Income Tax Expense
822393265181705136243155271484585217235601132249214199232
Net Income
3,8642,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,3792,8411,6162,1431,3171,4761,899
Net Income to Common
3,8642,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,3792,8411,6162,1431,3171,4761,899
Net Income Growth (YoY)
20.15%65.85%5.15%112.60%13.64%91.96%--18.25%63.58%-45.90%--52.54%-19.27%4.71%92.48%-14.90%13.75%183.84%-10.33%17.59%
Shares Outstanding (Basic)
541540540539538538538537537537536535535535534535535535548562
Shares Outstanding (Diluted)
546544544543542541541542542541536540538537538539538537551565
Shares Change (YoY)
0.74%0.56%0.56%0.18%--0.93%0.37%0.74%0.74%-0.37%0.19%---2.36%-4.60%-5.61%-6.77%-5.16%-3.42%
EPS (Basic)
7.144.403.372.475.982.663.221.175.271.39-0.211.433.232.585.323.024.012.462.693.38
EPS (Diluted)
7.084.373.342.465.932.653.201.165.221.38-0.211.423.222.575.282.993.982.452.683.36
EPS Growth (YoY)
19.39%64.91%4.38%112.07%13.60%92.03%--18.73%62.11%-46.30%--52.42%-19.10%4.90%97.02%-10.90%20.24%202.55%-5.30%21.72%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
3,6543,4891,4779614,2481,9119804,4003,3142,2214592892,5123,8387202,3092,8181,6841,9742,521
Free Cash Flow Per Share
6.696.412.711.777.843.531.818.126.114.110.860.544.677.151.344.285.243.143.584.46
Dividend Per Share
2.5202.5202.5202.3802.3802.3802.3802.2502.2502.2502.2502.1302.1302.1302.1301.9401.9401.9401.9401.760
Dividend Growth (YoY)
5.88%5.88%5.88%5.78%5.78%5.78%5.78%5.63%5.63%5.63%5.63%9.79%9.79%9.79%9.79%10.23%10.23%10.23%10.23%10.00%
Gross Margin
73.10%72.64%71.03%72.88%71.29%70.89%68.03%70.15%68.85%69.29%66.33%70.03%73.84%74.05%71.83%74.45%76.13%77.10%74.98%74.91%
Operating Margin
35.79%35.55%33.80%30.55%34.15%32.63%28.73%28.62%31.85%30.63%23.53%39.01%27.15%38.09%33.89%31.26%39.90%33.00%39.92%34.40%
Profit Margin
37.28%23.62%21.11%13.51%33.65%15.60%21.23%6.90%33.28%8.89%-1.52%9.36%25.06%19.74%46.54%23.63%32.22%19.97%23.66%27.74%
Free Cash Flow Margin
35.25%34.70%17.14%9.74%44.45%20.82%12.03%48.43%38.97%26.48%6.16%3.53%36.39%54.94%11.79%33.76%42.36%25.54%31.64%36.82%
EBITDA
4,8324,6864,0294,0224,5714,3363,7283,8864,1043,9693,1514,4382,7693,5572,9693,0493,4913,0043,3313,207
EBITDA Margin
46.62%46.61%46.75%40.77%47.83%47.24%45.75%42.77%48.27%47.32%42.31%54.15%40.11%50.92%48.63%44.58%52.48%45.56%53.40%46.84%
D&A For EBITDA
1,1221,1121,1161,0081,3071,3411,3871,2861,3961,4001,3991,241895896900911837828841852
EBIT
3,7103,5742,9133,0143,2642,9952,3412,6002,7082,5691,7523,1971,8742,6612,0692,1382,6542,1762,4902,355
EBIT Margin
35.79%35.55%33.80%30.55%34.15%32.63%28.73%28.62%31.85%30.63%23.53%39.01%27.15%38.09%33.89%31.26%39.90%33.00%39.92%34.40%
Effective Tax Rate
17.54%14.20%12.72%11.96%17.98%8.67%12.32%19.82%8.74%6.04%-9.98%11.14%14.56%17.46%7.55%10.41%13.98%11.88%10.89%
Revenue as Reported
10,36510,0548,6189,8669,5579,1798,1499,0868,5038,3887,4478,1966,9036,9866,1056,8396,6526,5946,2386,846
SEC Filings: 10-K · 10-Q